Insider Trading & Ownership of Kanya Rajangam

Location: South San Francisco, CA
Summary: The estimated net worth of Kanya Rajangam is at least $382K dollars as of 11 Mar 2025. Kanya Rajangam is the Pres. & Chief Med. & Dev. Off. of Senti Biosciences, Inc. and owns shares of Senti Biosciences, Inc. (SNTI) stock worth about $270K. Kanya Rajangam is the Chief Medical Officer of Nkarta, Inc. and owns shares of Nkarta, Inc. (NKTX) stock worth about $112K.
Signature: /s/ Robert Cutler, attorney-in-fact
All Insider Reports: All Insider Reports

Notify me when Kanya Rajangam files a new Insider Trading report.

Ownership of Kanya Rajangam

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
SNTI	Senti Biosciences, Inc.	Pres. & Chief Med. & Dev. Off.	$270K	-$6.07K	-2.2%	10 Mar 2025
NKTX	Nkarta, Inc.	Chief Medical Officer	$112K			14 Jan 2022
TSBX	Turnstone Biologics Corp.	Director				03 Jun 2024

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.